<DOC>
	<DOCNO>NCT01680029</DOCNO>
	<brief_summary>To evaluate performance safety PBASE-system use treatment acute migraine episode moderate severe intensity . The study evaluate effect treatment migraine pain symptom acute attack also long-term effect .</brief_summary>
	<brief_title>PBASE-system Acute Migraine Clinical Investigation</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Willing able provide write informed consent prior participation clinical investigation Male female age 18 65 year Diagnosed suffer migraine without aura accord IHS classification ( ICHDII ) Reported history 2 6 migraine episode per month previous 3 month , confirm prospective baseline period one month Reported history le 50 % migraine episodes involve moderate severe pain intensity , confirm prospective baseline period one month Reported history least 48 hour freedom headache migraine attack , confirm prospective baseline period one month Reported history majority untreated migraine attack duration last 8 hour Onset migraine headache occur age 50 Reported history migraine one year Able willing maintain current preventive headache medication regimen ( ) ( change type , frequency dose ) baseline screen visit 2 week posttreatment Able understand complete electronic diary Experiencing acute migraine attack moderate severe pain intensity time treatment Treatment possible within 5 hour migraine onset Reported history 15 headache day per month ( i.e . headache kind ) , confirm prospective baseline period one month Reported frequency nonmigraine headache exceed 6 day per month , confirm prospective baseline period one month Unable distinguish migraine headache headache type onset migraine attack Treatment Botox receive within 6 month screen visit , screen treatment visit Previously treat implantable stimulator implantable device head and/or neck Diagnosed pronounced anterior septal deviation History sinus surgery , transphenoidal surgery pituitary lesion CSF rhinorrhea Fitted pacemaker /defibrillator Previously treat radiation face Ongoing bacterial infection nasal cavity History nose bleeds ( epistaxis ) Ongoing malignancy nasal cavity Concomitant condition could cause excessive bleed Known allergy polyvinylchloride , material use fabrication balloon part Catheter A100 , medicinal liquid paraffin Concurrent condition risk noncompliance , investigator 's opinion , may affect interpretation performance safety data otherwise contraindicate participation clinical investigation Any change migraine prophylaxis screen treatment visit Women childbearing potential pregnant risk become pregnant prior treatment phase Participation clinical research study within 3 month enrolment plan participation time clinical investigation Considered meet definition vulnerable Investigator 's opinion Headache migraine episode within 48 hour prior treatment PRN ( require ) acute migraine medication ( ) take within 48 hour prior treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>